In a systematic review and meta-analysis, researchers sought to compare outcomes associated with the use of lasmiditan, rimegepant, and ubrogepant vs triptans for the acute management of migraine headaches.
The HER-MES trial included 777 adults with episodic or chronic migraine (at least 4 migraine days/month) who were treatment-naïve, not suitable for, or had previously failed up to 3 prophylactic migraine treatments.
Seglentis is a co-crystal formulation of celecoxib, an NSAID, and tramadol hydrochloride, an opioid agonist and inhibitor of norepinephrine and serotonin reuptake.
Zimhi is intended for immediate administration as emergency therapy in settings where opioids may be present.
In light of Pain Awareness and Arthritis Awareness Month, Lawrence Edwards, MD, discusses the importance of addressing pain in patients with gout and the role of collaboration between clinical specialties during the management of painful gout flares.
Sleep disturbance in older adults is associated with physical pain and depression.
The utility of urine drug tests for identifying potential opioid prescription misuse was examined in this study.
GAPNA discusses how advanced practice practitioners are well-positioned to encourage healthy lifestyles among older adults, to include activities that help attain/maintain lean muscle mass, regardless of BMI, to reduce chronic pain and frailty.
Opioid dose tapering may be linked to increased risk for overdose and mental health crises in patients taking long-term, high-dose opioids.
A survey of 100 cancer patients revealed a high interest in CBD use, but most patients would prefer receiving more information from qualified sources.
